SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD Shanghai Labway Clinical Laboratory Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 2,056.06 million compared to CNY 769.58 million a year ago. Revenue was CNY 2,060.66 million compared to CNY 771.29 million a year ago.
Net income was CNY 430.55 million compared to CNY 98.18 million a year ago. Basic earnings per share from continuing operations was CNY 1.075 compared to CNY 0.2786 a year ago. Diluted earnings per share from continuing operations was CNY 1.075 compared to CNY 0.2786 a year ago.
